NCT06175741

Brief Summary

The aim of the study is to determine the efficacy of adding morphine in two doses (3mg, 5mg) to erector spinae plane block in relieving acute post mastectomy pain

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 19, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

June 6, 2024

Status Verified

June 1, 2024

Enrollment Period

1.4 years

First QC Date

November 30, 2023

Last Update Submit

June 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • total morphine consumption

    . If the VAS score more than 3 rescue postoperative analgesia in the form of PCA morphine with initial bolus of 0.1mg/kg will be administered once the patient exhibit pain , followed by a 1 mg bolus with a locked period of 15 minutes when no background infusion will be permitted, total amount of morphine will be consumed be the patient will be recorded.

    during 24 hours post operative

Secondary Outcomes (7)

  • Time of first analgesic request

    2,4,6,8,12,24 hours post operative

  • VAS at rest and movement

    2,4,6,8,12,24 hours post operative

  • Mean blood pressure (MBP)

    Pre operative,intra operative and post operative at 2,4,6,8,12,24 hours post operative

  • Number of participants with morphine side effects

    2,4,6,8,12,24 hours post operative

  • Ramsay sedation scale

    2,4,6,8,12,24 hours post operative

  • +2 more secondary outcomes

Study Arms (3)

Control group

PLACEBO COMPARATOR

this group will receive erector spinae plane block only(bupivicaine)

Procedure: erector spinae plane block

Interventional 3mg

EXPERIMENTAL

this group will receive erector spinae plane block (bupivicaine and 3mg morphine)

Procedure: erector spinae plane block

Interventional 5mg

EXPERIMENTAL

this group will receive erector spinae plane block (bupivicaine and 5mg morphine)

Procedure: erector spinae plane block

Interventions

The ultrasound (US)-guided ESP block will be provided while the patient be in a seated position according to surgical site (right or left). Using high-frequency linear US transducer , the probe is placed in the longitudinal orientation lateral to thoracic third and six spinous processes ,then the trapezius muscle ,rhomboids major muscle and erector spinae muscle are identified and we will inject 20ml of 0.25% bupivacaine into interfacial plane below erector spinae muscle in one level (between T3and T6) ,alone in 1st group,with 3 mg morphine in 2nd group and 5 mg morphine in 3rd group

Control groupInterventional 3mgInterventional 5mg

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • /female patients aged from 18 to 60 years.
  • /ASA I -II
  • /Surgery is modified radical mastectomy

You may not qualify if:

  • /ASA more than II
  • /Patients with known allergy to study drugs
  • /Skin infection at site of needle puncture
  • /Coagulopathy
  • /Uncooperative patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (14)

  • Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, Dworkin RH. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain. 2006 Sep;7(9):626-34. doi: 10.1016/j.jpain.2006.02.007.

    PMID: 16942948BACKGROUND
  • Fecho K, Miller NR, Merritt SA, Klauber-Demore N, Hultman CS, Blau WS. Acute and persistent postoperative pain after breast surgery. Pain Med. 2009 May-Jun;10(4):708-15. doi: 10.1111/j.1526-4637.2009.00611.x. Epub 2009 Apr 22.

    PMID: 19453965BACKGROUND
  • Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North Am. 2005 Mar;23(1):21-36. doi: 10.1016/j.atc.2004.11.013.

    PMID: 15763409BACKGROUND
  • Weltz CR, Greengrass RA, Lyerly HK. Ambulatory surgical management of breast carcinoma using paravertebral block. Ann Surg. 1995 Jul;222(1):19-26. doi: 10.1097/00000658-199507000-00004.

    PMID: 7618963BACKGROUND
  • Sekandarzad MW, van Zundert AAJ, Lirk PB, Doornebal CW, Hollmann MW. Perioperative Anesthesia Care and Tumor Progression. Anesth Analg. 2017 May;124(5):1697-1708. doi: 10.1213/ANE.0000000000001652.

    PMID: 27828796BACKGROUND
  • Cali Cassi L, Biffoli F, Francesconi D, Petrella G, Buonomo O. Anesthesia and analgesia in breast surgery: the benefits of peripheral nerve block. Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1341-1345.

    PMID: 28387892BACKGROUND
  • Zhao J, Han F, Yang Y, Li H, Li Z. Pectoral nerve block in anesthesia for modified radical mastectomy: A meta-analysis based on randomized controlled trials. Medicine (Baltimore). 2019 May;98(18):e15423. doi: 10.1097/MD.0000000000015423.

    PMID: 31045802BACKGROUND
  • Bakshi SG, Karan N, Parmar V. Pectoralis block for breast surgery: A surgical concern? Indian J Anaesth. 2017 Oct;61(10):851-852. doi: 10.4103/ija.IJA_455_17. No abstract available.

    PMID: 29242663BACKGROUND
  • Naja Z, Lonnqvist PA. Somatic paravertebral nerve blockade. Incidence of failed block and complications. Anaesthesia. 2001 Dec;56(12):1184-8. doi: 10.1046/j.1365-2044.2001.02084-2.x.

    PMID: 11736777BACKGROUND
  • Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.

    PMID: 27501016BACKGROUND
  • El Mourad MB, Amer AF. Effects of adding dexamethasone or ketamine to bupivacaine for ultrasound-guided thoracic paravertebral block in patients undergoing modified radical mastectomy: A prospective randomized controlled study. Indian J Anaesth. 2018 Apr;62(4):285-291. doi: 10.4103/ija.IJA_791_17.

    PMID: 29720754BACKGROUND
  • Hassan ME, Mahran E. Evaluation of the role of dexmedetomidine in improvement of the analgesic profile of thoracic paravertebral block in thoracic surgeries: A randomised prospective clinical trial. Indian J Anaesth. 2017 Oct;61(10):826-831. doi: 10.4103/ija.IJA_221_17.

    PMID: 29242655BACKGROUND
  • Lozano-Diaz D, Valdivielso Serna A, Garrido Palomo R, Arias-Arias A, Tarraga Lopez PJ, Martinez Gutierrez A. Validation of the Ramsay scale for invasive procedures under deep sedation in pediatrics. Paediatr Anaesth. 2021 Oct;31(10):1097-1104. doi: 10.1111/pan.14248. Epub 2021 Jul 11.

    PMID: 34173295BACKGROUND
  • Herrera FJ, Wong J, Chung F. A systematic review of postoperative recovery outcomes measurements after ambulatory surgery. Anesth Analg. 2007 Jul;105(1):63-9. doi: 10.1213/01.ane.0000265534.73169.95.

    PMID: 17578958BACKGROUND

Study Officials

  • shereen Mamdouh

    south Egypt cancer institute ,Assiut university

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal invistigator

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 19, 2023

Study Start

September 1, 2024

Primary Completion

February 1, 2026

Study Completion

March 1, 2026

Last Updated

June 6, 2024

Record last verified: 2024-06